Author:
Share Mohammadi Hadi,Haghighi Asl Ali,Khajenoori Maryam
Reference48 articles.
1. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis;Cocquyt;Eur. J. Cancer,2001
2. Olanzapine versus Aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial;Navari;J. Support. Oncol.,2011
3. Evaluation of particle size reduction on dissolution and oral bioavailability of aprepitant;Zhang;Nanomed. Nano Tech. Biol. Med.,2016
4. Effects of expansion parameters on characteristics of gemfibrozil powder produced by rapid expansion of supercritical solution process;Baseri;Powder Technol.,2014
5. Perspectives on the amorphisation/milling relationship in pharmaceutical materials;Descamps;Adv. Drug Deliv. Rev.,2016